CARE Ratings Share Price | CARE Ratings Stock Screener
CARERATING
Rating Services
Share Price NSE
₹1658.80
▼
-14.30 (-0.85%)
Share Price BSE
₹1660.10
▼
-12.95 (-0.77%)
As of May 27, 2026, the CARE Ratings share price (NSE: CARERATING) is ₹1,658.80 on NSE and ₹1,660.10 on BSE, down 0.85% from the previous close, with shares trading between ₹1,633.50 and ₹1,697.70, and a 52-week range of ₹1,412.50–₹1,939.20.
Check CARERATING 52-week high low for the annual price range and momentum.
Use the CARE Ratings stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
CARE Ratings Market Cap
₹5,070.73 Cr.
CARERATING P/E Ratio (TTM)
29.90
CARE Ratings P/B Ratio
5.57
EPS (TTM)
₹57.06
Dividend Yield
1.27%
Debt to Equity
0.03
CARERATING 52 Week High
₹1939.20
CARE Ratings 52 Week Low
₹1412.50
Operating Margin
46.00%
Profit Margin
36.99%
CARERATING Revenue (TTM)
₹146.00
EBITDA
₹77.00
Net Income
₹54.00
Total Assets
₹1,105.00
Total Equity
₹933.00
CARE Ratings Share Price Chart
Screen CARE Ratings share price with an interactive chart. Analyse CARERATING price trends and volatility across different timeframes.
CARE Ratings Company Profile - Fundamental Screener
Screen CARE Ratings company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for CARERATING shares.
Sector
Financial Services
Industry
Rating Services
Sub-Sector
Rating Services
Segment
E
ISIN
INE752H01013
CARE Ratings Balance Sheet Screener
Screen CARERATING balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,105 | 958 | 842 | 770 | 727 | 672 | 619 | 615 | 659 | 585 |
| Current Assets | 677 | 692 | 675 | 602 | 564 | 546 | 296 | 279 | 341 | 440 |
| Fixed Assets | 120 | 119 | 109 | 107 | 96 | 85 | 93 | 83 | 60 | 61 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 44 | 44 | 39 | 33 | 23 | 26 | 23 | 14 | 10 | 15 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 933 | 816 | 725 | 679 | 653 | 593 | 537 | 552 | 599 | 521 |
| Share Capital | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 |
| Reserves & Surplus | 902 | 776 | 687 | 643 | 618 | 559 | 480 | 499 | 559 | 490 |
CARE Ratings Income Statement Screener - Profit & Revenue Analysis
Screen CARE Ratings income statement and profit fundamentals.
Analyze CARERATING quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for CARE Ratings share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 146 | 125 | 108 | 149 | 125 | 100 | 91 | 129 | 108 | 88 | 78 | 108 | 92 | 73 | 62 |
| Expenses | 70 | 62 | 66 | 68 | 72 | 61 | 57 | 62 | 66 | 50 | 49 | 55 | 55 | 43 | 38 |
| EBITDA | 77 | 63 | 41 | 81 | 53 | 39 | 34 | 68 | 42 | 38 | 29 | 53 | 37 | 30 | 24 |
| Operating Profit % | 46.00% | 43.00% | 30.00% | 50.00% | 36.00% | 32.00% | 28.00% | 47.00% | 32.00% | 35.00% | 27.00% | 43.00% | 30.00% | 34.00% | 30.00% |
| Depreciation | 4 | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 |
| Profit Before Tax | 72 | 59 | 37 | 77 | 49 | 36 | 30 | 64 | 39 | 34 | 26 | 50 | 34 | 27 | 21 |
| Tax | 19 | 16 | 11 | 20 | 13 | 12 | 9 | 17 | 10 | 14 | 8 | 14 | 10 | 4 | 7 |
| Net Profit | 54 | 43 | 27 | 57 | 37 | 25 | 21 | 47 | 28 | 20 | 18 | 36 | 24 | 23 | 14 |
| EPS | 17.58 | 14.24 | 8.61 | 18.90 | 11.96 | 8.07 | 6.94 | 15.41 | 9.30 | 6.60 | 6.00 | 11.83 | 7.88 | 7.72 | 4.61 |
CARE Ratings Cash Flow Screener - Liquidity Fundamentals
Screen CARERATING cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 123 | 91 | 82 | 68 | 86 | 67 | 109 | 134 | 119 | 106 |
| Investing Activities | -58 | -39 | 13 | -27 | -38 | 27 | 83 | -25 | -22 | -41 |
| Financing Activities | -54 | -63 | -63 | -35 | -43 | -107 | -195 | -99 | -96 | -66 |
| Net Cash Flow | 11 | -11 | 32 | 6 | 5 | -13 | -4 | 11 | 1 | -1 |
CARE Ratings Shareholding Pattern Screener
See CARE Ratings shareholding pattern with promoter, FII, and DII holdings.
Check CARE Ratings promoter holding and ownership changes for CARERATING on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| FII Holding | 23.25% | 23.74% | 24.62% | 23.61% | 23.00% | 22.91% | 23.37% | 24.80% |
| DII Holding | 31.39% | 29.38% | 29.76% | 31.60% | 31.30% | 26.89% | 26.15% | 25.28% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.94% | 25.48% | 25.04% | 24.78% | 25.33% | 27.95% | 28.00% | 27.64% |
| Other Holding | 20.43% | 21.39% | 20.59% | 20.01% | 20.36% | 22.26% | 22.48% | 22.28% |
| Shareholder Count | 58,978 | 51,395 | 61,111 | 56,931 | 59,139 | 52,468 | 53,140 | 53,602 |
CARE Ratings Share Dividend Screener - Share Yield Analysis
Check CARE Ratings dividend history with payout and yield data.
View CARE Ratings dividend details including ex-dates and amounts for CARERATING stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹18.00 | 1.24% |
| 2024-March | ₹18.00 | 1.63% |
| 2023-March | ₹25.00 | 2.23% |
| 2022-March | ₹17.00 | 2.64% |
| 2021-March | ₹17.00 | 3.33% |
| 2020-March | ₹19.50 | 4.74% |
| 2019-March | ₹30.00 | 9.16% |
| 2018-March | ₹55.00 | 5.56% |
| 2017-March | ₹28.00 | 2.32% |
CARE Ratings Stock Index Membership
See which indices include CARE Ratings stock.
Check CARERATING index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX SMLCAP
FINANCIAL SERVICES
CARE Ratings Market Events Screener - Corporate Actions
Get CARE Ratings corporate actions including splits, bonuses, and buybacks.
Check CARE Ratings stock events that may affect CARERATING share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2022-11-18 | Buyback | 515 | -3.22% | |
| Dividend | ₹ 10.00 /share | 9.92% | ||
| Dividend | ₹ 6.00 /share | 15.10% | ||
| 2026-07-03 | 2026-07-03 | Annual General Meeting | NA | 9.15% |
| 2026-06-25 | 2026-06-26 | Dividend | ₹ 14.00 /share | 9.15% |
| 2026-05-13 | 2026-05-13 | Quarterly Result Announcement | NA | -0.37% |
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | 0.49% |
| 2025-11-19 | 2025-11-19 | Dividend | ₹ 8.00 /share | -3.68% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -0.31% |
| 2025-08-05 | 2025-08-05 | Quarterly Result Announcement | NA | -9.49% |
| 2025-07-10 | 2025-07-10 | Annual General Meeting | NA | 40.63% |
| 2025-06-27 | 2025-06-27 | Dividend | ₹ 11.00 /share | 36.20% |
| 2025-05-12 | 2025-05-12 | Quarterly Result Announcement | NA | 6.48% |
| 2025-01-30 | 2025-01-30 | Quarterly Result Announcement | NA | 4.03% |
| 2024-11-05 | 2024-11-05 | Dividend | ₹ 7.00 /share | 32.68% |
CARE Ratings Competitors Screener - Peer Comparison
Screen CARERATING competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| CRISIL | 29,447 | 35.54 | 3,756 | 12.13% | 766 | 41.63 |
| ICRA | 5,239 | 28.52 | 600 | 4.19% | 186 | 52.85 |
| CARE Ratings | 5,071 | 29.90 | 473 | 4.41% | 173 | 52.86 |
CARE Ratings Company Announcements - News Screener
Screen CARERATING latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - | |
| 2026-05-25 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-14 | Audio Recording Of Earnings Conference Call For The Quarter And Year Ended March 31 2026 | - |
| 2026-05-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-13 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-13 | Annual General Meeting On July 3 2026 | - |
| 2026-05-13 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | - |
| 2026-05-13 | Grant Of Esops To Eligible Employees | - |
| 2026-05-13 | Corporate Action - Record Date For Final Dividend | - |
| 2026-05-13 | Corporate Action-Board approves Dividend | - |
| 2026-05-13 | Financial Results For Quarter And Financial Year Ended March 31 2026 | - |
| 2026-05-13 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-05-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-04 | Allotment Of Equity Shares Pursuant To Exercise Of ESOP And Grant Of Stock Options Under CARE Employee Stock Option Scheme 2020 | - |
| 2026-05-04 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-05-04 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-04-30 | Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-04-28 | Board Meeting Intimation for To Consider And Approve The Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Financial Year Ended On March 31 2026 And To Recommend Final Dividend If Any For The Financial Year 2025-26 | - |